Biostatistics and Clinical Innovation Industry and Regulator Forum

Gain access to novel, thought-provoking findings and collaborate with experts on charting the best path forward in biostatistics and clinical trial innovation.

Early Bird Ends

DAYS

HOURS

MINUTES

SECONDS

Send Email 1.888.257.6457

Back to Agenda

Closing Remarks and Next Steps

Session Chair(s)

Maria Vassileva, PhD

Chief Science and Regulatory Officer

DIA, United States

Closing Remarks and Next Steps

Have an account?

Biostatistics and Clinical Innovation Industry and Regulator Forum

Closing Remarks and Next Steps

Session Chair(s)

Maria Vassileva, PhD

Be informed and stay engaged.